ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120103. A total of 49 filers reported holding ATYR PHARMA INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $44,000 | +10.0% | 79,677 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $40,000 | -38.5% | 79,677 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $65,000 | -11.0% | 79,677 | 0.0% | 0.00% | -33.3% |
Q2 2018 | $73,000 | -65.4% | 79,677 | 0.0% | 0.00% | -66.7% |
Q1 2018 | $211,000 | -24.4% | 79,677 | 0.0% | 0.01% | -25.0% |
Q4 2017 | $279,000 | -30.6% | 79,677 | 0.0% | 0.01% | -36.8% |
Q3 2017 | $402,000 | +46.2% | 79,677 | 0.0% | 0.02% | +35.7% |
Q2 2017 | $275,000 | -1.4% | 79,677 | 0.0% | 0.01% | -6.7% |
Q1 2017 | $279,000 | +63.2% | 79,677 | 0.0% | 0.02% | +36.4% |
Q4 2016 | $171,000 | -32.4% | 79,677 | 0.0% | 0.01% | -31.2% |
Q3 2016 | $253,000 | -98.9% | 79,677 | -84.6% | 0.02% | -95.4% |
Q2 2016 | $22,422,000 | +1330.0% | 518,910 | +30.5% | 0.35% | +1495.5% |
Q1 2016 | $1,568,000 | -61.6% | 397,783 | -4.2% | 0.02% | -62.7% |
Q4 2015 | $4,083,000 | -4.2% | 415,377 | 0.0% | 0.06% | -11.9% |
Q3 2015 | $4,262,000 | -44.6% | 415,377 | 0.0% | 0.07% | -42.2% |
Q2 2015 | $7,693,000 | – | 415,377 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|